Thromboresistance Comparison of the HeartMate II Ventricular Assist Device With the Device Thrombogenicity Emulation-Optimized HeartAssist 5 VAD

Approximately 7.5 × 10(6) patients in the US currently suffer from end-stage heart failure. The FDA has recently approved the designations of the Thoratec HeartMate II ventricular assist device (VAD) for both bridge-to-transplant and destination therapy (DT) due to its mechanical durability and impr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chiu, Wei-Che, Girdhar, Gaurav, Xenos, Michalis, Alemu, Yared, Soares, Jõao S., Einav, Shmuel, Slepian, Marvin, Bluestein, Danny
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Mechanical Engineers 2014
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023653/
https://ncbi.nlm.nih.gov/pubmed/24337144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1115/1.4026254
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller